ZNF763
gene geneOn this page
Also known as ZNF440L
Summary
ZNF763 (zinc finger protein 763, HGNC:27614) is a protein-coding gene on chromosome 19p13.2, encoding Zinc finger protein 763 (Q0D2J5). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus.
Source: NCBI Gene 284390 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 1 total
- MANE Select transcript:
NM_001367172
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27614 |
| Approved symbol | ZNF763 |
| Name | zinc finger protein 763 |
| Location | 19p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | ZNF440L |
| Ensembl gene | ENSG00000197054 |
| Ensembl biotype | protein_coding |
| Entrez | 284390 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 5 protein_coding
ENST00000343949, ENST00000358987, ENST00000481745, ENST00000586494, ENST00000592625
RefSeq mRNA: 4 — MANE Select: NM_001367172
NM_001012753, NM_001367172, NM_001367173, NM_001367174
CCDS: CCDS45982, CCDS92522
Canonical transcript exons
ENST00000358987 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001411647 | 11978116 | 11980617 |
| ENSE00001708936 | 11965040 | 11965211 |
| ENSE00003481030 | 11977038 | 11977164 |
| ENSE00003527623 | 11977371 | 11977431 |
Expression profiles
Bgee: expression breadth ubiquitous, 184 present calls, max score 87.49.
FANTOM5 (CAGE): breadth broad, TPM avg 1.6083 / max 28.7072, expressed in 901 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 173972 | 1.6083 | 901 |
| 173975 | 1.4562 | 583 |
Top tissues by expression
233 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.49 | gold quality |
| granulocyte | CL:0000094 | 75.94 | gold quality |
| bronchial epithelial cell | CL:0002328 | 75.36 | gold quality |
| buccal mucosa cell | CL:0002336 | 74.99 | silver quality |
| left ovary | UBERON:0002119 | 74.77 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 74.51 | gold quality |
| calcaneal tendon | UBERON:0003701 | 74.32 | gold quality |
| mucosa of stomach | UBERON:0001199 | 73.98 | gold quality |
| bronchus | UBERON:0002185 | 73.80 | gold quality |
| right ovary | UBERON:0002118 | 73.79 | gold quality |
| metanephros cortex | UBERON:0010533 | 73.50 | gold quality |
| body of pancreas | UBERON:0001150 | 73.48 | gold quality |
| ventricular zone | UBERON:0003053 | 73.35 | gold quality |
| jejunal mucosa | UBERON:0000399 | 73.17 | gold quality |
| ovary | UBERON:0000992 | 72.99 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 72.71 | gold quality |
| pancreas | UBERON:0001264 | 72.53 | gold quality |
| islet of Langerhans | UBERON:0000006 | 72.50 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 72.40 | gold quality |
| lower esophagus | UBERON:0013473 | 72.35 | gold quality |
| spleen | UBERON:0002106 | 72.12 | gold quality |
| cortex of kidney | UBERON:0001225 | 72.06 | gold quality |
| leukocyte | CL:0000738 | 71.90 | gold quality |
| ganglionic eminence | UBERON:0004023 | 71.86 | gold quality |
| cortical plate | UBERON:0005343 | 71.84 | gold quality |
| right adrenal gland | UBERON:0001233 | 71.67 | gold quality |
| apex of heart | UBERON:0002098 | 71.67 | gold quality |
| monocyte | CL:0000576 | 71.53 | gold quality |
| blood | UBERON:0000178 | 71.53 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 71.45 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.91 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): CTCF
miRNA regulators (miRDB)
77 targeting ZNF763, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-188-3P | 100.00 | 68.76 | 1240 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-3925-3P | 100.00 | 69.95 | 1237 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-433-3P | 99.98 | 69.37 | 1203 |
| HSA-MIR-3692-3P | 99.98 | 70.27 | 2139 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7B-5P | 99.98 | 72.31 | 1790 |
| HSA-LET-7C-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7E-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7F-5P | 99.98 | 72.56 | 1784 |
| HSA-LET-7G-5P | 99.98 | 72.37 | 1784 |
| HSA-LET-7I-5P | 99.98 | 72.37 | 1788 |
| HSA-MIR-98-5P | 99.98 | 72.33 | 1787 |
| HSA-MIR-548AN | 99.97 | 70.91 | 2817 |
| HSA-LET-7D-5P | 99.96 | 71.76 | 1632 |
| HSA-MIR-4458 | 99.96 | 71.64 | 1650 |
| HSA-MIR-6845-3P | 99.94 | 66.88 | 1439 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-4493 | 99.90 | 66.48 | 977 |
| HSA-MIR-6499-3P | 99.90 | 66.38 | 1212 |
| HSA-MIR-4302 | 99.89 | 67.94 | 1187 |
| HSA-MIR-605-3P | 99.88 | 69.22 | 1833 |
| HSA-MIR-3151-5P | 99.86 | 63.83 | 1069 |
| HSA-MIR-4447 | 99.85 | 67.81 | 2900 |
| HSA-MIR-3156-3P | 99.76 | 66.72 | 939 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp78 | ENSMUSG00000055150 |
| rattus_norvegicus | ENSRNOG00000083797 | |
| drosophila_melanogaster | CG2712 | FBGN0024975 |
| drosophila_melanogaster | Phs | FBGN0036522 |
| drosophila_melanogaster | CG3281 | FBGN0260741 |
Paralogs (62): ZNF582 (ENSG00000018869), ZNF264 (ENSG00000083844), ZNF343 (ENSG00000088876), ZNF684 (ENSG00000117010), ZNF133 (ENSG00000125846), ZNF557 (ENSG00000130544), ZNF337 (ENSG00000130684), ZNF20 (ENSG00000132010), ZFP37 (ENSG00000136866), ZNF614 (ENSG00000142556), KRBOX4 (ENSG00000147121), ZNF599 (ENSG00000153896), ZNF19 (ENSG00000157429), ZNF589 (ENSG00000164048), PRDM9 (ENSG00000164256), ZNF180 (ENSG00000167384), ZNF558 (ENSG00000167785), ZNF35 (ENSG00000169981), ZNF778 (ENSG00000170100), ZNF439 (ENSG00000171291), ZNF440 (ENSG00000171295), ZNF556 (ENSG00000172000), ZNF554 (ENSG00000172006), ZNF596 (ENSG00000172748), ZNF80 (ENSG00000174255), ZNF266 (ENSG00000174652), ZNF25 (ENSG00000175395), ZNF77 (ENSG00000175691), ZNF169 (ENSG00000175787), ZNF404 (ENSG00000176222), ZNF491 (ENSG00000177599), ZNF620 (ENSG00000177842), ZNF619 (ENSG00000177873), ZNF875 (ENSG00000181666), ZNF329 (ENSG00000181894), ZFP90 (ENSG00000184939), ZNF566 (ENSG00000186017), ZNF529 (ENSG00000186020), ZNF749 (ENSG00000186230), ZNF555 (ENSG00000186300)
Protein
Protein identifiers
Zinc finger protein 763 — Q0D2J5 (reviewed: Q0D2J5)
All UniProt accessions (4): Q0D2J5, K7EJ80, K7EJF3, K7ESF6
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q0D2J5-1 | 1 | yes |
| Q0D2J5-2 | 2 | |
| Q0D2J5-3 | 3 |
RefSeq proteins (4): NP_001012771, NP_001354101, NP_001354102, NP_001354103 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352, PF13912
UniProt features (14 total): zinc finger region 8, splice variant 2, sequence variant 2, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q0D2J5-F1 | 67.53 | 0.25 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 49 (showing top):
OSMAN_BLADDER_CANCER_DN, chr19p13, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, STK33_SKM_UP, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ZNF22_TARGET_GENES, MIR6809_3P, MIR6833_3P, MIR6873_3P, MIR203A_3P, MIR1827, MIR4768_5P, MIR7154_5P, MIR605_3P, GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (7): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity (GO:0003700), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872), sequence-specific double-stranded DNA binding (GO:1990837)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 2 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| transcription cis-regulatory region binding | 1 |
| transcription regulator activity | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
12 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF763 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| GADD45G | ZNF763 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF763 | SUFU | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF763 | CSNK2A2 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF69 | ZNF763 | psi-mi:“MI:0914”(association) | 0.350 |
| SUFU | ZNF763 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (7): KRTAP10-3 (Two-hybrid), ZNF763 (Synthetic Growth Defect), ZNF763 (Two-hybrid), ZNF763 (Two-hybrid), ZNF763 (Affinity Capture-MS), ZNF763 (Affinity Capture-MS), ZNF763 (Affinity Capture-RNA)
ESM2 similar proteins: A0A1W2PQL4, A0JPL0, A2RRD8, A6NHJ4, A6NP11, B4DX44, O75346, O95780, P0CB33, P21506, P51508, P52738, Q0D2J5, Q0VGE8, Q12901, Q13360, Q14593, Q15973, Q2M218, Q2M3X9, Q2VY69, Q3SXZ3, Q5HY98, Q5RCJ2, Q5VIY5, Q6J6I6, Q7L2R6, Q86XU0, Q86Y25, Q8IW36, Q8IYN0, Q8IYX0, Q8N782, Q8N883, Q8N9Z0, Q8NDP4, Q95K49, Q969W8, Q96H40, Q96N58
Diamond homologs: A0JPK3, A8MT65, C9JN71, E9QAG8, G3X9G7, O75820, P16373, P16374, P16415, P17017, P17024, P17025, P51815, P52737, Q08AG5, Q08ER8, Q0D2J5, Q15973, Q2M218, Q3KP31, Q3V080, Q494X3, Q4R4C7, Q5MYW4, Q5R9F0, Q5R9S5, Q5REI6, Q5REK1, Q68EA5, Q6P560, Q6P5C7, Q6ZQV5, Q7L945, Q86T29, Q8BGV5, Q8C6P8, Q8IYI8, Q8IZC7, Q8N7K0, Q8N972
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
674 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:11978115:GGA:G | acceptor_gain | 1.0000 |
| 19:11965207:A:T | donor_gain | 0.9900 |
| 19:11977023:T:G | acceptor_gain | 0.9900 |
| 19:11978106:C:G | acceptor_gain | 0.9900 |
| 19:11978110:T:TA | acceptor_gain | 0.9900 |
| 19:11978111:GACA:G | acceptor_loss | 0.9900 |
| 19:11978114:A:AG | acceptor_gain | 0.9900 |
| 19:11978114:AG:A | acceptor_gain | 0.9900 |
| 19:11978115:G:GA | acceptor_loss | 0.9900 |
| 19:11978115:G:GG | acceptor_gain | 0.9900 |
| 19:11978115:GG:G | acceptor_gain | 0.9900 |
| 19:11978115:GGAGT:G | acceptor_gain | 0.9900 |
| 19:11965206:G:GT | donor_gain | 0.9800 |
| 19:11977022:ATGT:A | acceptor_gain | 0.9800 |
| 19:11977164:GGT:G | donor_loss | 0.9800 |
| 19:11977164:GGTA:G | donor_loss | 0.9800 |
| 19:11977165:G:GC | donor_loss | 0.9800 |
| 19:11977166:T:A | donor_loss | 0.9800 |
| 19:11977367:TTAGG:T | acceptor_loss | 0.9800 |
| 19:11977368:TA:T | acceptor_loss | 0.9800 |
| 19:11977369:AG:A | acceptor_gain | 0.9800 |
| 19:11977370:G:GA | acceptor_loss | 0.9800 |
| 19:11977370:GG:G | acceptor_gain | 0.9800 |
| 19:11977427:TTCAG:T | donor_loss | 0.9800 |
| 19:11977428:TCAG:T | donor_loss | 0.9800 |
| 19:11977429:CAGG:C | donor_loss | 0.9800 |
| 19:11977430:AGGTA:A | donor_loss | 0.9800 |
| 19:11977431:GG:G | donor_loss | 0.9800 |
| 19:11977432:G:GC | donor_loss | 0.9800 |
| 19:11977433:T:G | donor_loss | 0.9800 |
AlphaMissense
2641 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:11978969:T:C | F349L | 0.983 |
| 19:11978971:C:A | F349L | 0.983 |
| 19:11978971:C:G | F349L | 0.983 |
| 19:11978633:T:C | F237L | 0.978 |
| 19:11978635:T:A | F237L | 0.978 |
| 19:11978635:T:G | F237L | 0.978 |
| 19:11978717:T:C | F265L | 0.972 |
| 19:11978719:C:A | F265L | 0.972 |
| 19:11978719:C:G | F265L | 0.972 |
| 19:11978801:T:C | F293L | 0.968 |
| 19:11978803:C:A | F293L | 0.968 |
| 19:11978803:C:G | F293L | 0.968 |
| 19:11978885:T:C | F321L | 0.965 |
| 19:11978887:C:A | F321L | 0.965 |
| 19:11978887:C:G | F321L | 0.965 |
| 19:11977071:T:C | F13L | 0.964 |
| 19:11977073:C:A | F13L | 0.964 |
| 19:11977073:C:G | F13L | 0.964 |
| 19:11977072:T:C | F13S | 0.943 |
| 19:11978900:T:C | S326P | 0.931 |
| 19:11977109:G:C | Q25H | 0.924 |
| 19:11977109:G:T | Q25H | 0.924 |
| 19:11978984:T:C | S354P | 0.923 |
| 19:11978842:C:A | H306Q | 0.922 |
| 19:11978842:C:G | H306Q | 0.922 |
| 19:11978926:C:A | H334Q | 0.919 |
| 19:11978926:C:G | H334Q | 0.919 |
| 19:11978732:T:C | S270P | 0.916 |
| 19:11978674:C:A | H250Q | 0.911 |
| 19:11978674:C:G | H250Q | 0.911 |
dbSNP variants (sampled 300 via entrez): RS1000031080 (19:11974612 C>G,T), RS1000307814 (19:11963343 C>G,T), RS1000711128 (19:11963142 T>TGCA), RS1000948702 (19:11972766 T>C), RS1001060725 (19:11967010 G>A), RS1001139525 (19:11967132 C>T), RS1001285468 (19:11964235 C>G), RS1001508907 (19:11966959 T>A), RS1001534800 (19:11975600 T>C), RS1001586926 (19:11975836 C>T), RS1001601021 (19:11967683 G>A), RS1001813890 (19:11969839 A>T), RS1001859868 (19:11979868 G>A,C), RS1001871898 (19:11974523 C>T), RS1001924228 (19:11974662 G>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008839_35 | Height | 2.000000e-07 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, decreases expression | 4 |
| trichostatin A | affects cotreatment, decreases expression | 3 |
| entinostat | affects cotreatment, decreases expression | 2 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | decreases expression, affects cotreatment | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Vorinostat | increases expression | 1 |
| Leflunomide | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Atrazine | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Lead | affects expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Asbestos, Crocidolite | decreases expression, increases methylation | 1 |
| Acrylamide | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.